A Breakthrough in Heart Valve Technology
A team of researchers at UBC Okanagan has developed a new heart valve that combines the best qualities of mechanical and tissue valves. This innovative valve, named the iValve, could significantly improve the lives of patients who require heart valve replacement.
Unlike traditional mechanical valves, which require patients to take daily anticoagulants, the iValve offers the durability of mechanical valves without the associated risks. It also outperforms tissue valves, which typically last only 15-20 years, by providing long-lasting performance.
The iValve was developed through an international collaboration and is the first of its kind to be designed and built in Canada. It is particularly promising for pediatric patients due to its design for high-heart-rate applications.
After successful mechanical lab tests, the researchers plan to conduct animal and clinical trials within the next two years. The iValve has the potential to revolutionize heart valve replacement by offering a safer and more effective solution for patients.